INTRODUCTION: Black smokers are reported to have higher lung cancer rates and greater tobacco dependence at lower levels of cigarette consumption compared to non-Hispanic White smokers. We studied the relationship between cigarettes per day (CPD) and biomarkers of nicotine and carcinogen exposure in Black and White smokers. METHODS: In 128 Black and White smokers, we measured plasma nicotine and its main proximate metabolite cotinine, urine nicotine equivalents, 4-(methylnitrosamino)-1-(3)pyridyl-1-butanol (NNAL), and polycyclic aromatic hydrocarbon (PAH) metabolites. RESULTS: The dose-response between CPD and nicotine equivalents, and NNAL and PAH was flat for Black but positive for White smokers (Race × CPD interaction, all ps < .05). Regression estimates for the Race × CPD interactions were 0.042 (95% CI 0.013-0.070), 0.054 (0.023-0.086), and 0.028 (0.004-0.052) for urine nicotine equivalents, NNAL, and PAHs, respectively. In contrast there was a strong correlation between nicotine equivalents and NNAL and PAH independent of race. Nicotine and carcinogen exposure per individual cigarette was inversely related to CPD. This inverse correlation was stronger in Black compared to White smokers and stronger in menthol compared to regular cigarette smokers (not mutually adjusted). CONCLUSIONS: Our data indicate that Blacks on average smoke cigarettes differently than White smokers such that CPD predicts smoke intake more poorly in Black than in White smokers.
INTRODUCTION: Black smokers are reported to have higher lung cancer rates and greater tobacco dependence at lower levels of cigarette consumption compared to non-Hispanic White smokers. We studied the relationship between cigarettes per day (CPD) and biomarkers of nicotine and carcinogen exposure in Black and White smokers. METHODS: In 128 Black and White smokers, we measured plasma nicotine and its main proximate metabolite cotinine, urine nicotine equivalents, 4-(methylnitrosamino)-1-(3)pyridyl-1-butanol (NNAL), and polycyclic aromatic hydrocarbon (PAH) metabolites. RESULTS: The dose-response between CPD and nicotine equivalents, and NNAL and PAH was flat for Black but positive for White smokers (Race × CPD interaction, all ps < .05). Regression estimates for the Race × CPD interactions were 0.042 (95% CI 0.013-0.070), 0.054 (0.023-0.086), and 0.028 (0.004-0.052) for urine nicotine equivalents, NNAL, and PAHs, respectively. In contrast there was a strong correlation between nicotine equivalents and NNAL and PAH independent of race. Nicotine and carcinogen exposure per individual cigarette was inversely related to CPD. This inverse correlation was stronger in Black compared to White smokers and stronger in menthol compared to regular cigarette smokers (not mutually adjusted). CONCLUSIONS: Our data indicate that Blacks on average smoke cigarettes differently than White smokers such that CPD predicts smoke intake more poorly in Black than in White smokers.
Authors: Assieh A Melikian; Mirjana V Djordjevic; Shuquan Chen; John Richie; Steven D Stellman Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-07 Impact factor: 4.254
Authors: Neal L Benowitz; Katherine M Dains; Delia Dempsey; Christopher Havel; Margaret Wilson; Peyton Jacob Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-10-20 Impact factor: 4.254
Authors: Jay H Lubin; Neil Caporaso; Dorothy K Hatsukami; Anne M Joseph; Stephen S Hecht Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-09 Impact factor: 4.254
Authors: Peyton Jacob; Christopher Havel; Do-Hoon Lee; Lisa Yu; Mark D Eisner; Neal L Benowitz Journal: Anal Chem Date: 2008-10-08 Impact factor: 6.986
Authors: Krista A Zanetti; Zhaoming Wang; Melinda Aldrich; Christopher I Amos; William J Blot; Elise D Bowman; Laurie Burdette; Qiuyin Cai; Neil Caporaso; Charles C Chung; Elizabeth M Gillanders; Christopher A Haiman; Helen M Hansen; Brian E Henderson; Laurence N Kolonel; Loic Le Marchand; Shengchao Li; Lorna Haughton McNeill; Bríd M Ryan; Ann G Schwartz; Jennette D Sison; Margaret R Spitz; Margaret Tucker; Angela S Wenzlaff; John K Wiencke; Lynne Wilkens; Margaret R Wrensch; Xifeng Wu; Wei Zheng; Weiyin Zhou; David Christiani; Julie R Palmer; Trevor M Penning; Alyssa G Rieber; Lynn Rosenberg; Edward A Ruiz-Narvaez; Li Su; Anil Vachani; Yongyue Wei; Alexander S Whitehead; Stephen J Chanock; Curtis C Harris Journal: Lung Cancer Date: 2016-05-13 Impact factor: 5.705
Authors: Samir S Khariwala; Steven G Carmella; Irina Stepanov; Dipankar Bandyopadhyay; Heather H Nelson; Bevan Yueh; Dorothy K Hatsukami; Stephen S Hecht Journal: Laryngoscope Date: 2015-04-15 Impact factor: 3.325
Authors: Taraneh Taghavi; Maria Novalen; Caryn Lerman; Tony P George; Rachel F Tyndale Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-05-31 Impact factor: 4.254
Authors: Cindy M Chang; Selvin H Edwards; Aarthi Arab; Arseima Y Del Valle-Pinero; Ling Yang; Dorothy K Hatsukami Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-11-09 Impact factor: 4.254
Authors: Ulla Broms; Marjaana Pennanen; Kristiina Patja; Hanna Ollila; Tellervo Korhonen; Aino Kankaanpää; Ari Haukkala; Annamari Tuulio-Henriksson; Markku Koskenvuo; Erkki Kronholm; Tiina Laatikainen; Markku Peltonen; Timo Partonen; Jaakko Kaprio Journal: J Addict Res Ther Date: 2012-01-25